A real world retrospective study comparing effectiveness of nab paclitaxel vs Eribulin for second line treatment in patients with metastatic breast cancer
Latest Information Update: 30 Nov 2016
At a glance
- Drugs Paclitaxel (Primary) ; Eribulin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 30 Nov 2016 New trial record
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress